Illinois Institute of Technology
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Illinois Institute of Technology sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Illinois Institute of Technology: 8 sponsored US clinical trials, 2 recruiting.
Illinois Institute of Technology sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Substance Addiction, with 1 trials.
Upper-quartile sponsor footprint
Illinois Institute of Technology sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
The Trans-Led Care Study
NCT06880705
A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness
NCT04634383
Air Filtration for COPD in VA Population of Veterans
NCT05913765
Chronic Pain, Couples, & Physical Activity
NCT04077164
Decreasing Body Dissatisfaction in Male College Athletes: A Randomized Controlled Trial of the Male Athlete Body Project
NCT04077177
Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness
NCT03382782
Residential Ventilation Systems and Filtration for Asthma Control in Adults
NCT06098287
Integrated Care & Patient Navigators for Latinos With Serious Mental Illness
NCT02469714
What is open in the Illinois Institute of Technology pipeline
2 recruiting of 8 indexed (25% open); 4 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Substance Addiction (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Illinois Institute of Technology: open-pipeline peers nationwide
Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Illinois Institute of Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 25% open enrollment (± trial volume)
- Abdul Latif Jameel Poverty Action Lab · 25% recruiting · 4 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
- Advocate Hospital System · 25% recruiting · 4 trials
Related
What to do with this Illinois Institute of Technology page
8 registered trials is a research-attention snapshot, not an endorsement of Illinois Institute of Technology or any single study.
- 2 of Illinois Institute of Technology's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Substance Addiction is the condition Illinois Institute of Technology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Substance Addiction trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Illinois Institute of Technology pipeline card: 8 registered trials from official public datasets.Report a data error.